SUSQUEHANNA INTERNATIONAL GROUP, LLP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,617
-77.3%
21,695
-47.6%
0.00%
Q2 2023$29,157
-6.9%
41,416
+18.8%
0.00%
Q1 2023$31,318
-29.1%
34,864
-6.9%
0.00%
Q4 2022$44,178
-95.3%
37,439
-70.2%
0.00%
Q3 2022$946,000
+131.3%
125,667
+93.8%
0.00%
Q2 2022$409,000
-70.5%
64,858
-61.2%
0.00%
Q1 2022$1,387,000
-12.3%
167,200
-45.1%
0.00%
Q4 2021$1,582,000
+33.5%
304,418
+71.6%
0.00%
Q3 2021$1,185,000
-57.6%
177,392
-45.9%
0.00%
Q2 2021$2,796,000
-8.1%
328,153
-4.6%
0.00%
Q1 2021$3,044,000
-68.8%
344,000
-56.6%
0.00%
Q4 2020$9,750,000
+222.5%
793,400
+113.7%
0.00%
Q3 2020$3,023,000
+1426.8%
371,346
+1179.2%
0.00%
Q1 2020$198,000
-57.4%
29,030
-7.0%
0.00%
Q4 2019$465,000
+220.7%
31,200
+120.7%
0.00%
Q3 2019$145,000
-88.2%
14,137
-87.8%
0.00%
Q2 2019$1,224,000
-3.7%
115,480
+27.0%
0.00%
-100.0%
Q1 2019$1,271,000
+166.5%
90,934
+93.6%
0.00%
Q4 2018$477,000
+318.4%
46,961
+226.4%
0.00%
Q2 2017$114,00014,3890.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 135,848$2,024,0006.74%
INTERWEST VENTURE MANAGEMENT CO 764,918$11,397,0004.91%
Knoll Capital Management, LLC 350,238$5,219,0003.85%
683 Capital Management, LLC 1,850,000$27,565,0003.15%
Soleus Capital Management, L.P. 205,407$3,060,0002.95%
Broadfin Capital, LLC 1,236,368$18,422,0002.47%
P.A.W. CAPITAL CORP 144,000$2,146,0002.29%
MANGROVE PARTNERS IM, LLC 847,284$12,625,0001.85%
Corriente Advisors, LLC 203,898$3,038,0001.63%
Trellus Management Company, LLC 63,850$951,0001.59%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders